Pioneering the Next Generation of
CAR-T Cell Therapies

Gracell is developing cell therapy with the goal of delivering fast,
deep and durable responses for people living with cancer and autoimmune disease

Learn More

Our Mission

We are a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative cell therapies that aim to address major industry challenges and fulfill unmet medical needs in the treatment of cancer and autoimmune diseases. We aim to disrupt conventional approaches to CAR-T cell therapies with our pioneering FasTCAR and TruUCAR technology platforms and SMART CART^TM technology module.

FasTCART ^™

Our FasTCART platform utilizes next-day manufacturing to generate younger, less exhausted CAR-T cells with potentially enhanced activities.

TruUCART ^™

We are exploring using our allogeneic platform to develop off-the-shelf CAR-T cell therapies with the goal of making cell therapy accessible to more patients.

SMART CART ^™

Our 2nd generation enhanced CAR-T molecule is designed to tackle challenges in treating solid tumors.

Pioneering the Next Generation of CAR-T Cell Therapies

Our Mission

FasTCART ™

TruUCART ™

SMART CART ™

Pioneering the Next Generation of
CAR-T Cell Therapies

FasTCART ^™

TruUCART ^™

SMART CART ^™